Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
CA 2413299 A1 · Owner: Smithkline Beecham Corporation · Inventors: Arch, Jonathan Robert Sanders; Lenhard, James Martin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for the treatment of diabetes mellitus especially Type 2 diabetes , and conditions associated with diabetes mellitus in a mammal such as a human which method comprises administering an effective non-toxic and , pharmaceutically acceptable amount of a dipeptidyl peptidase IV inhibitor and another antidiabetic agent, to a mammal in need thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 19, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.